Naturex Sa

Galderma S.a.

Naturex

Université D'avignon Et Des Pays De Vaucluse

Avignon Université

Givaudan France Naturals Sas

Universite D'avignon Et Des Pay De Vaucluse

Scionix Limited

Givaudan France Naturals

Antoine Charles Bily

Marc Roller

Simona Birtic

Farid Chemat

Laurent Chantalat

Philippe Andres

Yin-Ku Lin

Loïc Le Bronec

Jean-Thomas Pierson

Nicolas Feuillere

Isabelle Cardinaud

Kan He

Jacques Dikansky

Alvin Ibarra

Naisheng Bai

Leila Denise Falcao

Karl Chevalier

Anne-Sylvie Fabiano Tixier

Natacha Rombaut

Alexis Lavaud

Michael Laguerre

Anne Sylvie Fabiano Tixier

Lise Laurençon

Marjolaine Meyer

Anne Passemard

Xavier Pierre François Mesnier

François-Xavier Henri Pierre

Xavier Pierre Mesnier

Francois-Xavier Henri Pierre

Melanie Marie-Paule Heudre

Andrew Peter Abbott

Mathieu Tenon

Robert Harris

Pascale Elizabeth Renée Fanca-berthon

Michaël Laguerre

Romain Lecozannet

Mélanie Marie-Paule Patricia Heudré

Mélanie Marie-Paule Patricia Heudre

Pascale Elizabeth Renée Fança-Berthon

Matthieu Tenon

Melanie Marie-Paule Patricia Heudre

Pascale Elizabeth Renée FANÇA-Berthon

Pascale Elizabeth Renée Fanca-Berthon

Pascale Elizabeth Fanca-Berthon

Lise Laurencon

A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising:

Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods

The present invention relates to processes for forming eutectic extracts, processes for purifying eutectic extracts and uses of the eutectic extracts such as in food-stuffs, pharmaceuticals, nutraceuticals and supplements, such as food supplements and sports supplements.

Eutectic extract formation and purification

The present invention relates to extracts fromsamara, processes for providing such extracts, and methods and uses of the extracts obtained. In particular, the present invention relates to the use of such extracts in reversing obesity-related and/or metabolic syndrome-related gut microbiota dysbiosis treatment, treating or preventing hepatic steatosis, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), and modulating and/or adjusting gut microbiota.

Therapeutic use of a Fraximus augustifolia extract

The present invention relates to an extract obtained from or obtainable from, a composition comprising an extract obtained from or obtainable from, processes for providing such an extract, and methods and uses relating to such extracts. In particular, the present invention relates to an extract or composition for use in treating or preventing inflammation, such as arthritis and joint inflammation.

Method for treating or preventing inflammation

A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising: (a) betaine or a hydrated form of betaine; (b) at least one hydrogen bond donor compound selected from the group consisting of polyols and organic acids; and (c) water with the proviso that the eutectic extraction solvent does not contain any exogenous sugar and/or amine salt and/or anion.

The invention relates to a novel organic solubilisation and/or extraction solvent comprising at least one compound selected from the group of saturated monocyclic terpenoids, to an extraction method using said solvent, and to extracts obtained by said method. More particularly, the invention relates to a novel use of para-menthane, a saturated terpenoid compound, as a solvent derived from natural substances, and also to a solvent comprising para-menthane.

Organic solubilisation and/or extraction solvent, extraction method using said solvent, and extracts obtained by said method

The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.

Extract from Indigo Naturalis and a process for preparing the same

A composition includes hesperdin and/or a Lamiaceae extract wherein a majority of the volatile components have been removed from the Lamiaceae extract. A method for applying the composition to a food such as meat, fish or poultry, including processed and fresh or unprocessed meat, poultry and fish is also provided.

Antimicrobial compositions

A composition for improving muscle metabolism in a subject and methods for manufacturing and using same. Embodiments include compositions having an extract ofand an extract of. An extract ofmay include amounts of ecdysterones including 20-hydroxyecdysone. An extract ofmy include salidrosides and rosavins, including rosavin. Suitable ingestion dosages of the composition may be operable to increase protein synthesis and reduce protein proteolysis in a subject.

Compositions and methods for improved muscle metabolism

Extract from indigo naturalis and a process for preparing the same

A composition includesextract and a Lamiaceae extract, wherein a majority of the volatile oil components have been removed from the Lamiaceae extract. A method for applying the composition to a food which includes but is not limited to fresh/unprocessed and processed meat, fish or poultry is also provided.

Aseed extract that can be administered for therapeutic treatment of a subject, including a human, by blocking fat synthesis, activating PPAR-alpha, increasing hypoglycemic activity, reducing bodyweight, controlling fasting plasma insulin levels against hyperinsulinemia, and promoting insulin sensitivity and causing a beneficial acute insulinotropic effect. Theseed extract includes, inter alia, an isolated compound (2S,3E,4S)2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-&#x3b2;-D-glucopyranosyl-&#x3b2;-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl)methyl ester, commonly called excelside A, an isolated compound (2S,3E,4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-&#x3b2;-D-glucopyranosyl-&#x3b2;-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl)2-(4-hydroxyphenyl)ethyl ester, commonly called excelside B, and the compounds GI5, GI3, nuzhenide, and oleoside dimethyl ester.

[object Object]

Growing community of inventors

Vedene, France

Antoine Charles Bily